Effects of empagliflozin, diet, or both on physical activity and sedentary behaviour in people with type 2 diabetes: analyses from the SEESAW trial
conference contribution
posted on 2020-10-13, 09:16 authored by Jack A Sargeant, James A King, Emma L Baldry, Danielle H Bodicoat, Charlotte L Edwardson, Kamlesh Khunti, David J Stensel, David R Webb, John P H Wilding, Tom Yates, Melanie J DaviesConference abstract
Funding
Boehringer Ingelheim investigator-initiated grant and in-kind support from NIHR Leicester BRC
History
Related Materials
- 1. DOI - Is supplement to 56th EASD Annual Meeting of the European Association for the Study of Diabetes
Citation
Diabetologia 63, 1–485 (2020). https://doi.org/10.1007/s00125-020-05221-5Source
56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)Version
- AM (Accepted Manuscript)
Published in
DIABETOLOGIAVolume
63Issue
SUPPL 1Pagination
S270 - S271Publisher
Springerissn
0012-186Xeissn
1432-0428Acceptance date
2020-05-27Copyright date
2020Available date
2021-08-25Publisher DOI
Spatial coverage
Vienna, AustriaTemporal coverage: start date
2020-09-21Temporal coverage: end date
2020-09-25Language
enPublisher version
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC